BioSpace News Archive

Policy

FDA targets abuse of rules to delay entry of generic drugs

FDA Commissioner Scott Gottlieb released a statement on new policies aimed to combat the practice of using certain agency requirements to block timely generic drug entry.

June 1, 2018
·
3 min read
·
Don McCormick
Policy

Right to Try Law and FDA Face Criticism from Law’s Author

The ink is barely dry on the recently-passed “Right to Try Act,” and the law’s author, Sen. Ron Johnson (R-Wis.) and U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb are butting heads.

June 1, 2018
·
3 min read
·
Mark Terry
Business

Amgen and MD Anderson to Collaborate on Broad Cancer Program

Amgen, and The University of Texas MD Anderson Cancer Center, announced two multi-year collaborative research deals for a broad range of cancer therapeutics.

June 1, 2018
·
2 min read
·
Mark Terry
Genetown

Neon Therapeutics Plans $115 Million IPO

Neon Therapeutics filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) and hopes to raise $115 million.

June 1, 2018
·
2 min read
·
Mark Terry